CRISPR Therapeutics AG (CRSP) Current Taxes (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Current Taxes of $638000.0 for Q1 2026, down 42.68% sequentially from $1.1 million in Q4 2025, and down 48.59% YoY from $1.2 million in Q1 2025.
CRISPR Therapeutics AG (CRSP) Current Taxes (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Current Taxes for 12 years, with the latest figure at $638000.0 in Q1 2026.
- Quarterly Current Taxes fell 48.59% year-over-year to $638000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $638000.0 (down 48.59% YoY) and the FY2025 annual result came in at $1.1 million, up 146.78% from the prior year.
- Current Taxes retreated to $638000.0 in Q1 2026 per CRSP's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Taxes peaked at $4.3 million in Q3 2022 and troughed at $135000.0 in Q4 2022.
- A 5-year average of $1.3 million and a median of $715000.0 in 2025 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2023 and 2024: Current Taxes tumbled 95.88% in 2023, then soared 376.14% in 2024.
- Over 5 years, Current Taxes stood at $135000.0 in 2022, then soared by 224.44% to $438000.0 in 2023, then rose by 2.97% to $451000.0 in 2024, then jumped by 146.78% to $1.1 million in 2025, then tumbled by 42.68% to $638000.0 in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $638000.0, $1.1 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | 494,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 494,000.00 |
| Mar 31, 2026 | 638,000.00 |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 715,000.00 |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 451,000.00 |
| Sep 30, 2024 | 838,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 438,000.00 |
| Sep 30, 2023 | 176,000.00 |
| Jun 30, 2023 | 558,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | 4.27 Mn |
| Jun 30, 2022 | 3.95 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 724,000.00 |
| Sep 30, 2021 | 3.27 Mn |